Amid worldwide economic uncertainty caused by COVID-19, medtech venture capital activity continued at a healthy pace in the first half of 2020. More than 40 financing deals of $1m-and-over passed Medtech Insight's news desk from January to June – a similar volume as in the same period in 2019.
Overall, venture investors played it safe, mostly providing medium-sized double-digit
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?